Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0000950170-24-046596

Options or other derivatives

  • Chief Financial Officer acquired 41,705 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kelly John Alexander Chief Financial Officer 2024-04-18 Grant or award · Restricted Stock Units +41,705 41,705 D
Loading xslF345X05/ownership.xml…